DrugCite
Search

SAIZEN

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Saizen Adverse Events Reported to the FDA Over Time

How are Saizen adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Saizen, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Saizen is flagged as the suspect drug causing the adverse event.

Most Common Saizen Adverse Events Reported to the FDA

What are the most common Saizen adverse events reported to the FDA?

Headache
68 (2.56%)
Convulsion
57 (2.14%)
Vomiting
43 (1.62%)
Pyrexia
41 (1.54%)
Fall
34 (1.28%)
Malaise
34 (1.28%)
Pneumonia
30 (1.13%)
Suicidal Ideation
28 (1.05%)
Depression
27 (1.01%)
Fatigue
23 (.86%)
Death
21 (.79%)
Show More Show More
Nausea
20 (.75%)
Pain In Extremity
19 (.71%)
Anxiety
18 (.68%)
Condition Aggravated
18 (.68%)
Dizziness
18 (.68%)
Hypertension
18 (.68%)
Abdominal Pain
17 (.64%)
Off Label Use
17 (.64%)
Arthralgia
16 (.6%)
Asthenia
16 (.6%)
Brain Neoplasm
16 (.6%)
Injection Site Pain
16 (.6%)
Neoplasm Progression
15 (.56%)
Pain
15 (.56%)
Rash
15 (.56%)
Vision Blurred
15 (.56%)
Balance Disorder
14 (.53%)
Hypoaesthesia
14 (.53%)
Aplastic Anaemia
13 (.49%)
Cerebrovascular Accident
13 (.49%)
Chest Pain
13 (.49%)
Glioma
13 (.49%)
Myalgia
13 (.49%)
Oedema Peripheral
13 (.49%)
Benign Intracranial Hypertension
12 (.45%)
Diarrhoea
12 (.45%)
Drug Exposure During Pregnancy
12 (.45%)
Nasopharyngitis
12 (.45%)
Syncope
12 (.45%)
Constipation
11 (.41%)
Dyspnoea
11 (.41%)
Epilepsy
11 (.41%)
Influenza
11 (.41%)
Injection Site Haematoma
11 (.41%)
Loss Of Consciousness
11 (.41%)
Meningioma
11 (.41%)
Respiratory Disorder
11 (.41%)
Suicide Attempt
11 (.41%)
Systemic Lupus Erythematosus
11 (.41%)
Tremor
11 (.41%)
Abnormal Behaviour
10 (.38%)
Aggression
10 (.38%)
Brain Mass
10 (.38%)
Brain Oedema
10 (.38%)
Craniopharyngioma
10 (.38%)
Diabetes Mellitus
10 (.38%)
Drug Dose Omission
10 (.38%)
Inappropriate Schedule Of Drug Admi...
10 (.38%)
Osteochondrosis
10 (.38%)
Pituitary Tumour Benign
10 (.38%)
Weight Decreased
10 (.38%)
Back Pain
9 (.34%)
Blindness
9 (.34%)
Contusion
9 (.34%)
Petit Mal Epilepsy
9 (.34%)
Surgery
9 (.34%)
Urinary Tract Infection
9 (.34%)
Viral Infection
9 (.34%)
Dysphagia
8 (.3%)
Ear Infection
8 (.3%)
Hypoglycaemia
8 (.3%)
Infection
8 (.3%)
Injection Site Rash
8 (.3%)
Injection Site Reaction
8 (.3%)
Lower Respiratory Tract Infection
8 (.3%)
Medication Error
8 (.3%)
Neoplasm Recurrence
8 (.3%)
Papilloedema
8 (.3%)
Sepsis
8 (.3%)
Alopecia
7 (.26%)
Angina Pectoris
7 (.26%)
Basal Cell Carcinoma
7 (.26%)
Cough
7 (.26%)
Dry Mouth
7 (.26%)
Fluid Retention
7 (.26%)
Gait Disturbance
7 (.26%)
Insulin-like Growth Factor Increase...
7 (.26%)
Leukaemia
7 (.26%)
Pancytopenia
7 (.26%)
Pneumonia Legionella
7 (.26%)
Scoliosis
7 (.26%)
Squamous Cell Carcinoma
7 (.26%)
Sudden Death
7 (.26%)
Vitamin D Deficiency
7 (.26%)
Carpal Tunnel Syndrome
6 (.23%)
Dehydration
6 (.23%)
Desmoid Tumour
6 (.23%)
Device Related Infection
6 (.23%)
Ear Operation
6 (.23%)
Hydrocephalus
6 (.23%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Saizen, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Saizen is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Saizen

What are the most common Saizen adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Saizen, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Saizen is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Saizen According to Those Reporting Adverse Events

Why are people taking Saizen, according to those reporting adverse events to the FDA?

Growth Hormone Deficiency
400
Product Used For Unknown Indication
127
Hypopituitarism
40
Body Height Below Normal
38
Growth Retardation
35
Turners Syndrome
34
Show More Show More
Small For Dates Baby
29
Blood Growth Hormone Decreased
16
Blood Growth Hormone
12
Off Label Use
10
Noonan Syndrome
9
Drug Use For Unknown Indication
7
Renal Failure Chronic
6
Dwarfism
6
Endocrine Disorder
5
Hypothalamo-pituitary Disorder
4
In Vitro Fertilisation
4
Congenital Anomaly
3
Pituitary Tumour
3
Bone Disorder
2
Brain Neoplasm
2
Prader-willi Syndrome
2
Septo-optic Dysplasia
2
Body Height Decreased
2
Renal Failure
2
Inguinal Hernia
2
Medulloblastoma
2
Infertility
2
Congenital Osteodystrophy
1
Cushings Syndrome
1
Body Height Abnormal
1
Hormone Level Abnormal
1
Radiotherapy To Brain
1
Foetal Growth Restriction
1
Cardiac Failure Chronic
1
Dysmorphism
1
Pituitary Hypoplasia
1
Attention Deficit/hyperactivity Dis...
1
Failure To Thrive
1
Pituitary Tumour Removal
1
Pituitary Cancer Metastatic
1
Hypothyroidism
1
Chromosomal Deletion
1
Ill-defined Disorder
1
Aggression
1
Cystic Fibrosis
1
Juvenile Arthritis
1
Renal Transplant
1
Elderly
1
Endometrial Disorder
1
Polychondritis
1

Drug Labels

LabelLabelerEffective
Saizen ClickeasyEMD Serono, Inc.13-APR-12
SaizenEMD Serono, Inc.13-APR-12

Saizen Case Reports

What Saizen safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Saizen. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Saizen.